Furthermore, CSPG4-specific mAb has been shown to inhibit growth, adhesion, and migration of cancer cells in vitro, and significantly reduces the tumorigenic power of cancer cells and mitigates metastases and recurrence in vivo (22). The gene discussed is CSPG4; the disease is cancer.